N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)picolinamide

Catalog No. :
ACKUJX804
CAS No. :
1610521-45-3
Molecular Formula :
C18H21BN2O3
Molecular Weight :
324.19

IUPAC Name:N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)picolinamide

N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)picolinamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$323.00Login to see priceInquiryInquiry
1g98%$809.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)picolinamide
IUPAC NameN-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)picolinamide
Molecular FormulaC18H21BN2O3
Molecular Weight324.19
SMILESCC1(C)OB(C2=CC(NC(=O)C3=NC=CC=C3)=CC=C2)OC1(C)C
InChI KeyCJULCRUIZBGNCX-UHFFFAOYSA-N
SynonymN-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)picolinamide;2-Pyridinecarboxamide, N-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-;Pyridine-2-carboxylic acid [3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-amide;N-[3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-2-pyridinecarboxamide
CAS No.1610521-45-3

Synthetic Route by SureRoute

1. ACKUJX804 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHZLA740 route compound structure diagram
    ACHZLA740210907-84-9 In Stock
  2. Plus
  3. ACGQAF842 route compound structure diagram
    ACGQAF84214783-00-7 In Stock
  4. Then
  5. ACKUJX804 route product structure diagram
    ACKUJX8041610521-45-3
Inquiry

2. ACKUJX804 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKUJX804 route product structure diagram
    ACKUJX8041610521-45-3
Inquiry

Comments (0)